Generic Name and Formulations:
Clindamycin (as phosphate) 1.2%, benzoyl peroxide 3.75%; gel.
Bausch Health Companies Inc.
Indications for ONEXTON:
Apply a pea-sized amount once daily.
History of regional enteritis, ulcerative or antibiotic-associated colitis.
Avoid eyes, mouth, lips, mucous membranes, broken skin, sun, UV light. Discontinue if significant diarrhea occurs. Pregnancy (Cat.C). Nursing mothers: not recommended.
Lincosamide antibiotic + antibacterial/keratolytic.
Additive irritation with other topical agents. Avoid erythromycin-containing products. Caution with other neuromuscular blocking agents.
Burning sensation, contact dermatitis, pruritus, rash; colitis (may be fatal).
Neurology Advisor Articles
- Excess Abdominal Obesity Linked to Severe Disability in Multiple Sclerosis
- Change in Dietary Patterns Over 5 Years in Early Multiple Sclerosis
- Biobank Data Suggest Vitamin D Reduces Risk for Multiple Sclerosis
- High-Dose Biotin May Be an Effective Treatment for Progressive MS
- Poor Functional Outcomes Tied to Depressive Symptoms in Multiple Sclerosis
- Managing Status Epilepticus in Palliative Care: Accounting for Patient and Family Experience
- Oxygen Desaturation Index Predicts AFib Risk in Ischemic Stroke
- Opioid Use Down With 'Enhanced Recovery After Surgery' Program
- Popular Heroin Inhalation Method Tied to Leukoencephalopathy
- Erenumab Superior to Placebo for Reducing Migraine Disability, Improving HRQoL